Furthermore, the expression of COX‐2 in CAF was examined by IHC in 43 patients with NPC, among which 16 patients with NPC were identified as high expression of COX‐2, the others were low expression of COX‐2. The gene discussed is PTGS2; the disease is nasopharyngeal carcinoma.